Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia

IMPORTANCE: Additional lipid-lowering therapy options are needed for patients who cannot achieve sufficient decreases in low-density lipoprotein cholesterol (LDL-C) levels using statins alone or for those who are statin intolerant. OBJECTIVE: To conduct a pooled analysis of phase 3 randomized clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Banach, Maciej, Duell, P. Barton, Gotto, Antonio M., Laufs, Ulrich, Leiter, Lawrence A., Mancini, G. B. John, Ray, Kausik K., Flaim, JoAnn, Ye, Zhan, Catapano, Alberico L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330832/
https://www.ncbi.nlm.nih.gov/pubmed/32609313
http://dx.doi.org/10.1001/jamacardio.2020.2314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330832/
https://www.ncbi.nlm.nih.gov/pubmed/32609313
http://dx.doi.org/10.1001/jamacardio.2020.2314

Ejemplares similares